Evidence map›Paper›PMID 41969565›Full record

ArticlePNAS nexus2026

Defensomes, counter-defensomes, and the remodeling of microbial communities.

Vinicius S Kavagutti, Angelina Beavogui, Nicolas Wiart, Patrick Wincker, Pedro H Oliveira

Abstract read
In one paragraph

Article in PNAS nexus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vinicius S KavaguttiGénomique Métabolique, Genoscope, Institut François Jacob, Commissariat à l'Énergie Atomique, CNRS, Université Evry, Université Paris-Saclay, 2 Rue Gaston Crémieux, Evry 91057, France.ORCID https://orcid.org/0000-0002-1692-0042
Angelina BeavoguiGénomique Métabolique, Genoscope, Institut François Jacob, Commissariat à l'Énergie Atomique, CNRS, Université Evry, Université Paris-Saclay, 2 Rue Gaston Crémieux, Evry 91057, France.ORCID https://orcid.org/0000-0003-4876-263X
Nicolas WiartCommissariat à l'Énergie Atomique, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, 2 Rue Gaston Crémieux, Evry 91057, France.ORCID https://orcid.org/0000-0001-9701-4262
Patrick WinckerGénomique Métabolique, Genoscope, Institut François Jacob, Commissariat à l'Énergie Atomique, CNRS, Université Evry, Université Paris-Saclay, 2 Rue Gaston Crémieux, Evry 91057, France.ORCID https://orcid.org/0000-0001-7562-3454
Pedro H OliveiraGénomique Métabolique, Genoscope, Institut François Jacob, Commissariat à l'Énergie Atomique, CNRS, Université Evry, Université Paris-Saclay, 2 Rue Gaston Crémieux, Evry 91057, France.ORCID https://orcid.org/0000-0003-3161-8367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria and mobile genetic elements (MGEs) have coevolved for billions of years in an enduring evolutionary arms race, leading to the emergence and diversification of a vast arsenal of defense and counter-defense systems. In the last recent years, high-throughput screening methods and genome-resolved metagenomics have markedly enhanced our understanding of the diversity and abundance of immune systems across cultured and uncultured microorganisms. This fueled subsequent interest in better understanding the dynamic tri-kingdom interplay between bacteria, bacteriophages, and eukaryotic cells, and led to renewed efforts to improve alternative antibacterial phage-based therapies. Here, we discuss the evolutionary and ecological dynamics underlying the bacteria-MGE arms race, recent findings on bacterial defensomes, MGE counter-defensomes, holodefensomes, and their key role in the development of microbiome-targeted therapies. To this end, we argue why and how highly conserved anti-MGE defense systems should be prioritized as promising targets for the development of next-generation bacterial inhibitors with broad biomedical relevance, supported by a comprehensive analysis of their distribution and diversity across bacteria.

Indexed as

anti-MGE immunitycore defensomeholodefensomehorizontal gene transfermobile genetic elementsphage therapy

Identifiers

PMID41969565
PMCPMC13064858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.